查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1853384

猪疫苗市场按疫苗类型、动物年龄、给药途径、包装类型、最终用户、疾病类型和分销管道划分－全球预测，2025-2032年

Swine Vaccines Market by Vaccine Type, Animal Age, Route Of Administration, Packaging Type, End User, Disease Type, Distribution Channel - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 183 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2032 年，猪隻疫苗市场规模将成长 28.9 亿美元，复合年增长率为 7.83%。

关键市场统计数据
基准年 2024 15.8亿美元
预计年份：2025年 17亿美元
预测年份 2032 28.9亿美元
复合年增长率 (%) 7.83%

本书全面概述了现代猪疫苗接种策略如何在不断发展的全球供应链中支撑猪群健康、生产韧性和农场层面的生物安全。

猪疫苗领域在动物健康、食品安全和农业经济的交汇点上发挥着至关重要的作用。在现代生猪生产系统中，疫苗接种已从偶尔采取的干预措施发展成为牛健康计画的重要组成部分，旨在保护生产力、动物福利以及公众对供应链的信任。集约化养殖、国际贸易以及病毒和细菌病原体的出现和再次出现所带来的日益增长的压力，进一步凸显了製定强有力的预防策略的必要性。因此，疫苗不再只是生物安全工具，而是直接影响农场韧性、抗菌药物管理和长期永续性的战略资产。

在农场之外，疫苗价值链涵盖了生产商、经销商、兽医、诊断服务提供者和监管机构，他们之间的互动决定了技术创新对该领域的影响速度。先进分子平台、改进的递送系统和数位健康工具的融合，使得更有针对性的疫苗接种方法成为可能。同时，生产者结构的变化、商业农场的整合以及消费者期望的转变，都造成了复杂的营运环境。因此，相关人员必须平衡眼前的营运需求与中长期在研发、低温运输物流和培训方面的投资，才能充分发挥疫苗接种作为现代猪隻健康管理基石的潜力。

科技、监管和商业性变革的整合如何将疫苗转变为一种综合解决方案，从而提高牛健康韧性和营运效率？

过去五年，随着技术、监管和商业性动态的融合，猪隻疫苗生态系统经历了加速变革，产业边界也随之重塑。在技​​术方面，新型抗原平台和佐剂技术的进步提高了疫苗的保护效力，同时减少了不良反应，并增强了疫苗与牛管理流程的兼容性。给药途径和包装方式的改进也同步进行，降低了操作复杂性，并为大规模养殖中的群体免疫接种提供了更多实际选择。病原体监测投入的增加进一步巩固了这些技术进步，提高了疫苗株选择的准确性，并缩短了从发现病原体到采取针对性应对措施的时间。

在商业性，策略伙伴关係和对生产能力的重点投资正在提升应对力应对区域需求波动和供应中断的能力。监管机构正在提供更清晰的安全评估和现场有效性指导，鼓励更严格的上市后监测和跨辖区标准的协调统一。同时，从低温运输遥测到牛层面的疫苗接种合规性追踪，数位化正在提升可追溯性，并为兽医和农场管理者提供更好的决策支援。总而言之，这些转变正在将疫苗从单一产品交易转变为一个整合解决方案，该方案结合了科学创新、营运支援和数据主导的洞察，从而大规模地保障牛健康。

评估2025年关税对猪疫苗供应链和产业韧性的营运、采购和监管方面的连锁影响

近期公布的2025年关税措施为猪疫苗供应链的相关人员带来了新的复杂性，影响到原料、成品和跨境合作。这些关税改变了进口零件和成品的实际成本结构，迫使製造商和委託製造製造商重新评估筹资策略和目前的生产分配。在许多情况下，这种调整加速了部分生产环节的在地化进程，或促使企业摆脱对单一国家的依赖，实现采购多元化。同时，经销商物流面临日益加剧的摩擦，需要重新谈判商业条款并采取更灵活的库存管理策略。

这些贸易变化不仅关乎成本和物流。区域监管协调和核准协议能够减少合格评定中的重复工作，其策略价值日益凸显。为此，一些公司正在加强与区域主管机关的合作，以简化审批流程，并确保关键生物製剂的持续供应。在研发方面，关税带来的复杂性促使国内生产者与学术机构加强合作，以保护疫苗研发管线免受国际波动的影响。生产商优先研发剂量最少、操作更简便的疫苗方案，而兽医和供应商则强调制定完善的紧急时应对计画，以应对不断变化的贸易环境，保障疫苗接种计划的持续开展。

透过对疫苗平台、动物年龄层、给药途径、包装形式、目标疾病、最终用户和分销管道的详细细分洞察，可以实现精准商业化。

深入分析市场细分，可以发现疫苗类型、动物年龄层、给药途径、包装形式、最终用户、目标疾病和分销管道等方面的动态差异，这些差异对产品开发和商业化都有不同的影响。疫苗类型涵盖DNA疫苗、灭活疫苗、减毒活疫苗、重组疫苗、次单位疫苗和减毒活病毒疫苗疫苗等多种平台，每种平台都具有独特的风险效益特征，影响着其在不同生产系统中的应用。动物年龄组包括种猪、育肥猪、生长猪、仔猪和离乳猪，其中种猪又进一步细分为公猪和母猪，它们各自具有特定的免疫窗口期和给药策略，以保护繁殖性能和仔猪健康。

给药途径的选择—注射、鼻腔给药或口服给药—会影响劳动力需求、动物压力以及大规模疫苗接种的机会。包装形式——多剂量瓶、预填充式注射器和管瓶——会影响低温运输需求、浪费率以及现场使用的便利性。最终用户涵盖商业农场、研究机构、兽医院和诊所，每个使用者群体都有不同的采购行为、合规要求和技术能力。特定疾病的疫苗包括猪瘟、猪丹毒、猪霉浆菌肺炎、猪环状病毒、猪繁殖与呼吸症候群、猪流感。针对这些疾病的疫苗在免疫抗原性特征和监管途径的复杂性方面各不相同。分销管道包括线上药局、兽医院和动物诊所。线上药局又可细分为企业网站和电子商务平台，这会影响行销、履约和售后服务支援策略。这种细分能够更细緻地确定研发投资的优先顺序、客製化通讯方式，并使商业模式与最终用户的实际情况相符。

区域对比分析重点阐述美洲、欧洲、中东和非洲以及亚太市场如何采取量身定制的疫苗研发、分发和监管策略。

猪疫苗的市场动态在成熟生产地区和新兴市场之间存在显着差异，这影响着产品设计、监管沟通和打入市场策略的优先事项。在美洲，集约化生产系统和一体化商业农场推动了对可扩展疫苗解决方案的需求，这些方案旨在优化劳动效率和群体免疫力。该地区重视稳健的供应链、可预测的监管流程以及强大的行业和兽医关係，这些都有助于快速推广有效的疫苗创新。

在欧洲、中东和非洲，监管的复杂性和多样化的生产模式既带来了挑战，也带来了机会。西欧市场强调严格的安全性和药物安全检测标准，而东欧、中东和非洲市场则往往需要成本效益高的配方和包装，以适应规模较小的生产和不同的低温运输基础设施。这种异质性支援模组化策略，将高效的平台与灵活的配送和包装方案相结合。在亚太地区，密集的生产基地和反覆发生的疾病爆发正在加速新型疫苗技术和大规模接种方法的应用。契约製造的快速扩张和本地研发能力的提升，使该地区成为技术创新和区域供应安全的中心。在所有地区，数位化分销管道和电子商务正在成为触达兽医专业人员和农民的补充途径，尤其是在传统分销网络面临结构性限制的地区。

产业领导者如何平衡平台创新、製造能力和策略伙伴关係，以确保竞争优势并加速产品普及？

领先企业正以差异化的策略进军猪隻疫苗领域，这些策略体现了其产品组合的专业化、地理重点和生技药品生产能力。一些企业优先考虑平台多元化，投资新一代抗原技术和佐剂系统，以扩大对多种病原体的保护范围，同时减少不利事件。另一些企业则专注于给药途径的创新和包装改进，以降低大规模商业运营中的剂量复杂性和产品浪费。製造商与兽医服务供应商之间的策略联盟有助于弥合「最后一公里」差距，透过将培训、诊断支援和现场监测整合到上市产品中，提高疫苗的普及率。

生产规模和满足严格品质标准的能力是核心竞争优势，灵活的製造外包安排也同样重要，它能够实现产能的快速扩张。严谨的智慧财产权管理和监管申报流程将决定新疫苗在不同核准时长地区的商业化速度。此外，越来越多的公司正与大学研究中心和公立兽医学院合作，共用研发风险并加速转化研究。这些综合方法凸显了该领域的成功取决于研发、卓越生产、监管策略和商业性执行的平衡发展。

为产业领导者提供切实可行的策略和营运建议，以增强疫苗创新、供应韧性和在生猪生产系统中的应用。

行业领导者应采取多管齐下的策略，将科学创新与切实可行的商业性和营运措施相结合，以加强疫苗推广和市场韧性。首先，优先投资于能够提供广泛保护并快速适应新出现的病毒株的平台技术，可以获得持久的竞争优势。在研发重点之外，针对性地改进接种方法和包装，可以减少现场操作中的阻力，并支持大规模疫苗宣传活动。

其次，建立更具韧性的采购和生产策略至关重要。这包括实现关键投入品供应商多元化、扩大区域製造地，以及利用灵活的製造外包关係，即使在贸易中断的情况下也能维持生产的连续性。第三，积极与监管机构沟通，透过明确资料预期并尽可能利用统一的核准途径，可以缩短产品上市时间。第四，企业应加强与兽医和农场服务提供者的伙伴关係，将疫苗接种纳入包含诊断、数据分析和培训在内的综合牛健康计画。最后，投资于供应链视觉化、低温运输监控和合规性追踪的数位化工具，可以提高营运的可靠性，并提供可操作的数据来优化疫苗接种效果。这些措施共同构成了一条切实可行的蓝图，有助于提升产品的相关性、商业性吸引力和农场层面的实际效果。

本文清楚概述了一种混合方法研究途径，该策略结合了深度访谈、文献综述、细分市场分析和专家检验，旨在得出可操作的见解。

本分析所依据的研究结合了定性和定量方法，以确保对疫苗价值链的各个环节进行全面、可靠的三角验证。主要研究包括对兽医、农民、生产商、经销商和监管机构的专家进行结构化访谈，以了解实际经验和策略重点。次要研究包括对科学文献、监管指南、专利申请和生产系统分析进行系统性回顾，以识别技术和政策趋势。这些研究成果透过三角分析方法进行整合，该方法协调了不同的观点并检验了新出现的主题。

透过细分市场映射，将产品属性与最终用户需求、管理实际情况和通路相匹配。交叉验证阶段引入了独立的专家评审小组，以检验假设并完善建议。调查方法的局限性透过记录资料缺口和不确定性领域，并在定量精度有限的情况下强调定性影响来解决。伦理考量和保密通讯协定指导了访谈的开展以及专有资讯的去识别化。这些方法的结合建构了一个可靠且可操作的依证，旨在为研发、製造、监管和商业领域的决策提供资讯支援。

一份简明扼要的综述，重点阐述了将疫苗创新转化为猪隻健康和生产韧性持续改善所需的策略重点和协作行动。

疫苗接种仍然是保护猪隻健康、维持生产连续性、维护大众对猪肉供应链信任的最有效、扩充性的手段。猪肉产业正处于曲折点，科学进步、贸易动态变化和养殖方式的改变需要生产者、兽医和政策制定者协调应对。成功与否取决于创新管道与实际供应机制的对接、增强区域生产和供应的韧性，以及深化将科学进步转化为日常牛管理实践的伙伴关係。

短期内，相关人员应着重采取营运措施以维持业务连续性，例如供应商多元化、优化库存策略以及改善低温运输监控。中期来看，对适应性强的疫苗平台、精简的监管策略以及扩大现场支援能力的投资，将决定哪些组织能够在已开发市场和新兴市场中主导。最终，能否将技术优势转化为可供不同终端使用者使用且切实可行的解决方案，将决定市场领导地位，更重要的是，还将推动动物健康和农场永续性的显着改善。

目录

第一章：序言

第二章调查方法

第三章执行摘要

第四章 市场概览

第五章 市场洞察

  • 创新mRNA疫苗平台，用于频谱猪流感预防
  • 采用针对猪繁殖与呼吸综合症病毒和猪环状病毒2型的单剂量联合疫苗，以减轻养殖场的疫苗接种压力
  • 扩大耐热疫苗配方，以改善在新兴的亚洲和拉丁美洲养猪市场的分销
  • 整合重组病毒载体技术以加速对经典猪瘟的免疫反应
  • 引入一种农场快速诊断工具，以指导有针对性的猪疫苗接种通讯协定
  • 简化主要生猪生产地区基因删除减毒活疫苗的监管核准流程
  • 精准畜牧业投资趋势：结合感测器数据和疫苗接种计划，优化畜群健康
  • 公私合营推动针对新出现的猪冠状病毒和流感病毒株的通用疫苗研究

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

8. 依疫苗类型分類的猪隻疫苗市场

  • DNA疫苗
  • 灭活疫苗
  • 减毒活疫苗
  • 重组疫苗
  • 次单位疫苗
  • 类毒素疫苗

9. 依动物年龄分類的猪隻疫苗市场

  • 育种者
    • 公猪
    • 母猪
  • 陈年猪肉
  • 生长猪
  • 小猪
  • 断奶仔猪

第十章 依给药途径分類的猪隻疫苗市场

  • 注射
  • 鼻腔
  • 口服

第十一章 猪疫苗市场依包装类型划分

  • 多剂量瓶
  • 预填充式注射器
  • 管瓶

第十二章 猪疫苗市场（依最终用户划分）

  • 商业农场
  • 研究所
  • 兽医诊所
  • 兽医诊所

第十三章 依疾病类型分類的猪隻疫苗市场

  • 猪霍乱
  • 丹毒
  • 肺炎霉浆菌
  • 猪环状病毒
  • 猪繁殖与呼吸综合症
  • 猪流感

第十四章 猪隻疫苗市场依通路划分

  • 网路药房
    • 公司网站
    • 电子商务平台
  • 兽医诊所
  • 兽医诊所

第十五章 各地区猪疫苗市场

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十六章 猪疫苗市场（依类别划分）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十七章 各国猪疫苗市场

  • 美国
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十八章 竞争格局

  • 2024年市占率分析
  • FPNV定位矩阵，2024
  • 竞争分析
    • Zoetis Inc.
    • Merck & Co., Inc.
    • Boehringer Ingelheim Animal Health GmbH
    • Elanco Animal Health Incorporated
    • Ceva Sante Animale SAS
    • Virbac SA
    • Vetoquinol SA
    • HIPRA, SA
    • Phibro Animal Health Corporation
    • IDT Biologika GmbH
Product Code: MRR-3A2E844FD486

The Swine Vaccines Market is projected to grow by USD 2.89 billion at a CAGR of 7.83% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 1.58 billion
Estimated Year [2025] USD 1.70 billion
Forecast Year [2032] USD 2.89 billion
CAGR (%) 7.83%

A compelling overview of how modern swine vaccination strategies underpin herd health, production resilience, and farm-level biosecurity across evolving global supply chains

The swine vaccines landscape occupies a pivotal role at the intersection of animal health, food security, and agricultural economics. In modern pork production systems, vaccination has evolved from an occasional intervention into an integral component of herd health programs that safeguard productivity, animal welfare, and public confidence in supply chains. Growing pressures from intensification, global trade, and the emergence and re-emergence of viral and bacterial pathogens have sharpened the need for robust preventive strategies. As a result, vaccines are not merely biosecurity tools but strategic assets that directly influence farm resilience, antimicrobial stewardship, and long-term sustainability.

Beyond farm gates, the vaccine value chain comprises manufacturers, distributors, veterinarians, diagnostic providers, and regulatory authorities whose interactions determine how rapidly innovations translate into field impact. The convergence of advanced molecular platforms, improved delivery systems, and digital health tools is enabling more targeted immunization approaches. At the same time, demographic shifts in producer profiles, consolidation among commercial farms, and shifting consumer expectations create a complex operating environment. Consequently, stakeholders must balance immediate operational demands with mid- to long-term investments in research, cold-chain logistics, and training to realize the full potential of vaccination as a cornerstone of modern swine health management.

How converging technological, regulatory, and commercial shifts are transforming vaccines into integrated solutions that enhance herd health resilience and operational efficiency

The past five years have witnessed accelerated change in the swine vaccines ecosystem as technological, regulatory, and commercial dynamics converge to reshape industry boundaries. On the technological front, novel antigen platforms and adjuvant science have advanced protective performance while reducing adverse reactions and improving compatibility with herd management routines. Parallel developments in administration routes and packaging have lowered handling complexity and expanded practical options for mass immunization in large-scale operations. These innovations have been reinforced by increasing investment in pathogen surveillance, which improves the precision of vaccine strain selection and shortens the time from detection to targeted response.

Commercially, strategic partnerships and targeted investments in manufacturing capacity have improved responsiveness to regional demand fluctuations and supply interruptions. Regulatory agencies have moved toward clearer guidance on safety evaluation and field efficacy, encouraging more rigorous post-market surveillance and harmonized standards across jurisdictions. Meanwhile, digitalization-ranging from cold-chain telemetry to herd-level vaccine compliance tracking-has enhanced traceability and decision support for veterinarians and farm managers. Collectively, these shifts are transforming vaccines from single-product transactions into integrated solutions that combine scientific innovation, operational support, and data-driven insights to secure herd health at scale.

Assessment of the cascading operational, sourcing, and regulatory consequences that 2025 tariff actions have imposed on swine vaccine supply chains and industry resilience

Recent tariff measures announced in 2025 have introduced a new layer of complexity for stakeholders in the swine vaccines supply chain, affecting inputs, finished products, and cross-border collaboration. As tariffs alter the effective cost structure for imported components and finished doses, manufacturers and contract producers have had to reassess sourcing strategies and near-term manufacturing allocations. In many cases, the adjustments have accelerated efforts to localize certain production steps or to diversify procurement away from single-country dependencies. At the same time, distributors and export-oriented suppliers face elevated friction in cross-border logistics, necessitating renegotiated commercial terms and more dynamic inventory management.

These trade shifts have implications beyond immediate cost and logistics. They have increased the strategic value of regional regulatory alignment and mutual recognition agreements that reduce duplication of conformity assessments. In response, several firms have intensified engagement with regional authorities to streamline approvals and maintain uninterrupted access to essential biological inputs. From a research perspective, tariff-driven complexity has also encouraged closer collaboration between domestic manufacturers and academic institutions to insulate vaccine pipelines from international volatility. For end users, the net effect has been a renewed focus on resilience: producers are prioritizing vaccine regimens that minimize administration frequency and simplify handling, while veterinarians and supply partners emphasize robust contingency planning to sustain immunization programs amid shifting trade conditions.

Detailed segmentation insights across vaccine platforms, animal age classes, administration routes, packaging configurations, disease targets, end users, and distribution channels informing targeted commercialization

A granular look at segmentation reveals differentiated dynamics across vaccine type, animal age category, administration route, packaging format, end user, disease focus, and distribution channels, each with distinct implications for product development and commercialization. Vaccine type diversity spans DNA vaccine, inactivated vaccine, live attenuated vaccine, recombinant vaccine, subunit vaccine, and toxoid vaccine platforms, and each platform presents a unique risk-benefit profile that influences adoption across production systems. Animal age segments include breeders, finishers, growers, piglets, and weaners, with breeders further differentiated into boars and sows, creating specific immunization windows and dosing strategies to protect reproductive performance as well as piglet health.

Administration route choices-between injection, nasal, and oral delivery-affect labor requirements, stress on animals, and opportunities for mass vaccination. Packaging type options, including multi dose bottle, pre filled syringe, and vial formats, determine cold-chain demands, wastage rates, and field usability. End users range from commercial farms to research institutes, veterinary clinics, and veterinary hospitals, and each category has different purchasing behaviors, compliance expectations, and technical capabilities. Disease-focused segmentation covers classical swine fever, erysipelas, mycoplasma pneumonia, porcine circovirus, porcine reproductive and respiratory syndrome, and swine influenza; vaccines targeted at these conditions vary in immunogenic profile and regulatory pathway complexity. Distribution channels include online pharmacies, veterinary clinics, and veterinary hospitals, with online pharmacies further segmented into company websites and e-commerce platforms, a distinction that influences marketing, fulfillment, and after-sales support strategies. Together, these segmentation lenses enable a more nuanced approach to prioritizing R&D investments, tailoring messaging, and aligning commercial models with end-user realities.

Comparative regional analysis clarifying how the Americas, Europe Middle East & Africa, and Asia-Pacific markets demand tailored vaccine development, distribution, and regulatory strategies

Regional dynamics in the swine vaccines arena differ markedly across established production zones and emerging growth markets, shaping priorities for product design, regulatory engagement, and market access strategies. In the Americas, high-intensity production systems and integrated commercial farms drive demand for scalable vaccination solutions that optimize labor efficiency and herd-level immunity. This region places a premium on robust supply chains, predictable regulatory processes, and strong industry-veterinarian relationships that support rapid uptake of validated vaccine innovations.

In Europe, Middle East & Africa, regulatory complexity and diverse production models create both challenges and opportunities. Western European markets emphasize stringent safety and pharmacovigilance standards, while segments in Eastern Europe, the Middle East, and Africa often require cost-effective formulations and packaging that accommodate smaller-scale operations and variable cold-chain infrastructure. This heterogeneity encourages modular strategies that combine high-efficacy platforms with adaptive delivery and packaging options. In the Asia-Pacific region, dense production hubs and recurring disease pressures accelerate adoption of novel vaccine technologies and mass-administration approaches. The rapid expansion of contract manufacturing and growing capabilities in local R&D institutions have made the region a focal point for both innovation and regional supply security. Across all regions, digital distribution channels and e-commerce are emerging as complementary pathways to reach veterinary professionals and farm managers, particularly where traditional distribution networks face structural constraints.

How leading industry players are balancing platform innovation, manufacturing capacity, and strategic partnerships to secure competitive advantage and accelerate product adoption

Leading corporate participants approach the swine vaccines space with differentiated strategies that reflect portfolio specialization, geographic focus, and capabilities in biologics manufacturing. Some firms prioritize platform diversification, investing in next-generation antigen technologies and adjuvant systems to broaden protection across multiple pathogens while reducing adverse events. Other organizations concentrate on route-of-administration innovations and packaging improvements to lower administration complexity and product wastage in large-scale commercial operations. Strategic alliances between manufacturers and veterinary service providers help bridge the final-mile gap and strengthen adoption by integrating training, diagnostic support, and field monitoring into commercial offerings.

Manufacturing scale and the ability to meet stringent quality standards are central competitive levers, as are flexible contract manufacturing arrangements that enable rapid capacity scaling. Intellectual property management and a disciplined approach to regulatory submissions determine how quickly new vaccines can be commercialized across regions with divergent approval timelines. Finally, an increasing number of companies are pursuing collaborative research with academic centers and public veterinary institutes to accelerate translational studies while sharing development risk. These combined approaches underscore that success in the sector depends on a balanced emphasis across R&D, manufacturing excellence, regulatory strategy, and commercial execution.

Practical strategic and operational recommendations that industry leaders can implement to enhance vaccine innovation, supply resilience, and adoption in swine production systems

Industry leaders should adopt a multi-pronged playbook that aligns scientific innovation with pragmatic commercial and operational measures to strengthen vaccine uptake and market resilience. First, prioritizing investments in platform technologies that enable broad-spectrum protection and rapid adaptability to emerging strains will yield durable competitive advantages. Complementing that R&D focus with targeted improvements in administration methods and packaging will reduce field friction and support mass vaccination campaigns.

Second, building more resilient sourcing and manufacturing strategies is essential. This includes diversifying key input suppliers, expanding regional manufacturing footprints, and using flexible contract manufacturing relationships to maintain continuity in times of trade disruption. Third, proactive regulatory engagement can shorten time-to-field by clarifying data expectations and leveraging harmonized approval pathways where available. Fourth, companies should expand partnerships with veterinarians and farm service providers to embed vaccination into comprehensive herd health programs that include diagnostics, data analytics, and training. Finally, investing in digital tools for supply-chain visibility, cold-chain monitoring, and compliance tracking will improve operational reliability and provide actionable data to optimize immunization outcomes. These steps, taken together, form an actionable roadmap to enhance product relevance, commercial traction, and farm-level impact.

Transparent overview of the mixed-method research approach that integrated primary interviews, literature synthesis, segmentation mapping, and expert validation to derive actionable insights

The research underpinning this analysis combined qualitative and quantitative techniques to ensure robust, triangulated insights across the vaccine value chain. Primary research included structured interviews with veterinarians, farm managers, manufacturers, distributors, and regulatory specialists to capture frontline experience and strategic priorities. Secondary research involved systematic review of scientific literature, regulatory guidance, patent filings, and production system analyses to contextualize technological and policy trends. These inputs were synthesized using a triangulation approach that reconciled disparate perspectives and validated emerging themes.

Segmentation mapping was applied to align product attributes with end-user needs, administration realities, and distribution pathways. A cross-validation stage incorporated independent expert review panels to challenge assumptions and refine recommendations. Methodological limitations were addressed by documenting data gaps and uncertainty ranges, and by emphasizing qualitative implications where quantitative precision was constrained. Ethical considerations and confidentiality protocols guided interview conduct and the anonymization of proprietary information. Together, these methods produced a defensible and actionable evidence base designed to inform decision-making across R&D, manufacturing, regulatory, and commercial domains.

Concise synthesis highlighting the strategic priorities and coordinated actions necessary for translating vaccine innovation into sustained improvements in swine health and production resilience

Vaccination remains the most effective and scalable tool to protect swine health, preserve production continuity, and support public confidence in the pork supply chain. The industry stands at an inflection point where scientific progress, shifting trade dynamics, and changing farm practices demand coordinated responses from manufacturers, veterinarians, and policy makers. Success will depend on aligning innovation pipelines with practical delivery mechanisms, strengthening regional manufacturing and supply resilience, and deepening partnerships that translate scientific advances into routine herd-level practices.

In the short term, stakeholders should focus on operational measures that preserve continuity-diversifying suppliers, optimizing inventory strategies, and improving cold-chain oversight. In the medium term, investments in adaptable vaccine platforms, streamlined regulatory strategies, and expanded field support capabilities will determine which organizations lead in both developed and emerging markets. Ultimately, the capacity to convert technical superiority into accessible, implementable solutions for diverse end users will define market leadership and, more importantly, drive measurable improvements in animal health and farm sustainability.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Innovations in mRNA vaccine platforms for broad-spectrum swine influenza protection
  • 5.2. Adoption of single-dose combination vaccines targeting PRRS and porcine circovirus type 2 to reduce farm vaccination stress
  • 5.3. Expansion of thermostable vaccine formulations for improved distribution in emerging Asian and Latin American swine markets
  • 5.4. Integration of recombinant viral vector technologies to accelerate immune response against classical swine fever
  • 5.5. Implementation of on-farm rapid diagnostic tools to guide targeted swine vaccine administration protocols
  • 5.6. Regulatory approval pathways streamlining for gene-deleted live attenuated vaccines in major pork producing regions
  • 5.7. Investment trends in precision livestock farming combining sensor data with vaccination scheduling for optimized herd health
  • 5.8. Public-private partnerships driving research on universal vaccines against emerging porcine coronaviruses and influenza strains

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Swine Vaccines Market, by Vaccine Type

  • 8.1. Dna Vaccine
  • 8.2. Inactivated Vaccine
  • 8.3. Live Attenuated Vaccine
  • 8.4. Recombinant Vaccine
  • 8.5. Subunit Vaccine
  • 8.6. Toxoid Vaccine

9. Swine Vaccines Market, by Animal Age

  • 9.1. Breeders
    • 9.1.1. Boars
    • 9.1.2. Sows
  • 9.2. Finishers
  • 9.3. Growers
  • 9.4. Piglets
  • 9.5. Weaners

10. Swine Vaccines Market, by Route Of Administration

  • 10.1. Injection
  • 10.2. Nasal
  • 10.3. Oral

11. Swine Vaccines Market, by Packaging Type

  • 11.1. Multi Dose Bottle
  • 11.2. Pre Filled Syringe
  • 11.3. Vial

12. Swine Vaccines Market, by End User

  • 12.1. Commercial Farms
  • 12.2. Research Institutes
  • 12.3. Veterinary Clinics
  • 12.4. Veterinary Hospitals

13. Swine Vaccines Market, by Disease Type

  • 13.1. Classical Swine Fever
  • 13.2. Erysipelas
  • 13.3. Mycoplasma Pneumonia
  • 13.4. Porcine Circovirus
  • 13.5. Porcine Reproductive And Respiratory Syndrome
  • 13.6. Swine Influenza

14. Swine Vaccines Market, by Distribution Channel

  • 14.1. Online Pharmacies
    • 14.1.1. Company Websites
    • 14.1.2. E Commerce Platforms
  • 14.2. Veterinary Clinics
  • 14.3. Veterinary Hospitals

15. Swine Vaccines Market, by Region

  • 15.1. Americas
    • 15.1.1. North America
    • 15.1.2. Latin America
  • 15.2. Europe, Middle East & Africa
    • 15.2.1. Europe
    • 15.2.2. Middle East
    • 15.2.3. Africa
  • 15.3. Asia-Pacific

16. Swine Vaccines Market, by Group

  • 16.1. ASEAN
  • 16.2. GCC
  • 16.3. European Union
  • 16.4. BRICS
  • 16.5. G7
  • 16.6. NATO

17. Swine Vaccines Market, by Country

  • 17.1. United States
  • 17.2. Canada
  • 17.3. Mexico
  • 17.4. Brazil
  • 17.5. United Kingdom
  • 17.6. Germany
  • 17.7. France
  • 17.8. Russia
  • 17.9. Italy
  • 17.10. Spain
  • 17.11. China
  • 17.12. India
  • 17.13. Japan
  • 17.14. Australia
  • 17.15. South Korea

18. Competitive Landscape

  • 18.1. Market Share Analysis, 2024
  • 18.2. FPNV Positioning Matrix, 2024
  • 18.3. Competitive Analysis
    • 18.3.1. Zoetis Inc.
    • 18.3.2. Merck & Co., Inc.
    • 18.3.3. Boehringer Ingelheim Animal Health GmbH
    • 18.3.4. Elanco Animal Health Incorporated
    • 18.3.5. Ceva Sante Animale SAS
    • 18.3.6. Virbac S.A.
    • 18.3.7. Vetoquinol S.A.
    • 18.3.8. HIPRA, S.A.
    • 18.3.9. Phibro Animal Health Corporation
    • 18.3.10. IDT Biologika GmbH

LIST OF FIGURES

  • FIGURE 1. GLOBAL SWINE VACCINES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL SWINE VACCINES MARKET SIZE, BY VACCINE TYPE, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL SWINE VACCINES MARKET SIZE, BY VACCINE TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL SWINE VACCINES MARKET SIZE, BY ANIMAL AGE, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL SWINE VACCINES MARKET SIZE, BY ANIMAL AGE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL SWINE VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL SWINE VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL SWINE VACCINES MARKET SIZE, BY PACKAGING TYPE, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL SWINE VACCINES MARKET SIZE, BY PACKAGING TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL SWINE VACCINES MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 11. GLOBAL SWINE VACCINES MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL SWINE VACCINES MARKET SIZE, BY DISEASE TYPE, 2024 VS 2032 (%)
  • FIGURE 13. GLOBAL SWINE VACCINES MARKET SIZE, BY DISEASE TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. GLOBAL SWINE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2032 (%)
  • FIGURE 15. GLOBAL SWINE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. GLOBAL SWINE VACCINES MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. AMERICAS SWINE VACCINES MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. NORTH AMERICA SWINE VACCINES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. LATIN AMERICA SWINE VACCINES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA SWINE VACCINES MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. EUROPE SWINE VACCINES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. MIDDLE EAST SWINE VACCINES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. AFRICA SWINE VACCINES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. ASIA-PACIFIC SWINE VACCINES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. GLOBAL SWINE VACCINES MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. ASEAN SWINE VACCINES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. GCC SWINE VACCINES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 28. EUROPEAN UNION SWINE VACCINES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 29. BRICS SWINE VACCINES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 30. G7 SWINE VACCINES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 31. NATO SWINE VACCINES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 32. GLOBAL SWINE VACCINES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 33. SWINE VACCINES MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 34. SWINE VACCINES MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. SWINE VACCINES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL SWINE VACCINES MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL SWINE VACCINES MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL SWINE VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL SWINE VACCINES MARKET SIZE, BY VACCINE TYPE, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL SWINE VACCINES MARKET SIZE, BY DNA VACCINE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL SWINE VACCINES MARKET SIZE, BY DNA VACCINE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL SWINE VACCINES MARKET SIZE, BY DNA VACCINE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL SWINE VACCINES MARKET SIZE, BY DNA VACCINE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL SWINE VACCINES MARKET SIZE, BY DNA VACCINE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL SWINE VACCINES MARKET SIZE, BY DNA VACCINE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL SWINE VACCINES MARKET SIZE, BY INACTIVATED VACCINE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL SWINE VACCINES MARKET SIZE, BY INACTIVATED VACCINE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL SWINE VACCINES MARKET SIZE, BY INACTIVATED VACCINE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL SWINE VACCINES MARKET SIZE, BY INACTIVATED VACCINE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL SWINE VACCINES MARKET SIZE, BY INACTIVATED VACCINE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL SWINE VACCINES MARKET SIZE, BY INACTIVATED VACCINE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL SWINE VACCINES MARKET SIZE, BY LIVE ATTENUATED VACCINE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL SWINE VACCINES MARKET SIZE, BY LIVE ATTENUATED VACCINE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL SWINE VACCINES MARKET SIZE, BY LIVE ATTENUATED VACCINE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL SWINE VACCINES MARKET SIZE, BY LIVE ATTENUATED VACCINE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL SWINE VACCINES MARKET SIZE, BY LIVE ATTENUATED VACCINE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL SWINE VACCINES MARKET SIZE, BY LIVE ATTENUATED VACCINE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL SWINE VACCINES MARKET SIZE, BY RECOMBINANT VACCINE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL SWINE VACCINES MARKET SIZE, BY RECOMBINANT VACCINE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL SWINE VACCINES MARKET SIZE, BY RECOMBINANT VACCINE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL SWINE VACCINES MARKET SIZE, BY RECOMBINANT VACCINE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL SWINE VACCINES MARKET SIZE, BY RECOMBINANT VACCINE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL SWINE VACCINES MARKET SIZE, BY RECOMBINANT VACCINE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL SWINE VACCINES MARKET SIZE, BY SUBUNIT VACCINE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL SWINE VACCINES MARKET SIZE, BY SUBUNIT VACCINE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL SWINE VACCINES MARKET SIZE, BY SUBUNIT VACCINE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL SWINE VACCINES MARKET SIZE, BY SUBUNIT VACCINE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL SWINE VACCINES MARKET SIZE, BY SUBUNIT VACCINE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL SWINE VACCINES MARKET SIZE, BY SUBUNIT VACCINE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL SWINE VACCINES MARKET SIZE, BY TOXOID VACCINE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL SWINE VACCINES MARKET SIZE, BY TOXOID VACCINE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL SWINE VACCINES MARKET SIZE, BY TOXOID VACCINE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL SWINE VACCINES MARKET SIZE, BY TOXOID VACCINE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL SWINE VACCINES MARKET SIZE, BY TOXOID VACCINE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL SWINE VACCINES MARKET SIZE, BY TOXOID VACCINE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL SWINE VACCINES MARKET SIZE, BY ANIMAL AGE, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL SWINE VACCINES MARKET SIZE, BY ANIMAL AGE, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL SWINE VACCINES MARKET SIZE, BY BREEDERS, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL SWINE VACCINES MARKET SIZE, BY BREEDERS, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL SWINE VACCINES MARKET SIZE, BY BREEDERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL SWINE VACCINES MARKET SIZE, BY BREEDERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL SWINE VACCINES MARKET SIZE, BY BREEDERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL SWINE VACCINES MARKET SIZE, BY BREEDERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL SWINE VACCINES MARKET SIZE, BY BREEDERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL SWINE VACCINES MARKET SIZE, BY BREEDERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL SWINE VACCINES MARKET SIZE, BY BOARS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL SWINE VACCINES MARKET SIZE, BY BOARS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL SWINE VACCINES MARKET SIZE, BY BOARS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL SWINE VACCINES MARKET SIZE, BY BOARS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL SWINE VACCINES MARKET SIZE, BY BOARS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL SWINE VACCINES MARKET SIZE, BY BOARS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL SWINE VACCINES MARKET SIZE, BY SOWS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL SWINE VACCINES MARKET SIZE, BY SOWS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL SWINE VACCINES MARKET SIZE, BY SOWS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL SWINE VACCINES MARKET SIZE, BY SOWS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL SWINE VACCINES MARKET SIZE, BY SOWS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL SWINE VACCINES MARKET SIZE, BY SOWS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL SWINE VACCINES MARKET SIZE, BY FINISHERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL SWINE VACCINES MARKET SIZE, BY FINISHERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL SWINE VACCINES MARKET SIZE, BY FINISHERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL SWINE VACCINES MARKET SIZE, BY FINISHERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL SWINE VACCINES MARKET SIZE, BY FINISHERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL SWINE VACCINES MARKET SIZE, BY FINISHERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL SWINE VACCINES MARKET SIZE, BY GROWERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL SWINE VACCINES MARKET SIZE, BY GROWERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL SWINE VACCINES MARKET SIZE, BY GROWERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL SWINE VACCINES MARKET SIZE, BY GROWERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL SWINE VACCINES MARKET SIZE, BY GROWERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL SWINE VACCINES MARKET SIZE, BY GROWERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL SWINE VACCINES MARKET SIZE, BY PIGLETS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL SWINE VACCINES MARKET SIZE, BY PIGLETS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL SWINE VACCINES MARKET SIZE, BY PIGLETS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL SWINE VACCINES MARKET SIZE, BY PIGLETS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL SWINE VACCINES MARKET SIZE, BY PIGLETS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL SWINE VACCINES MARKET SIZE, BY PIGLETS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL SWINE VACCINES MARKET SIZE, BY WEANERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL SWINE VACCINES MARKET SIZE, BY WEANERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL SWINE VACCINES MARKET SIZE, BY WEANERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL SWINE VACCINES MARKET SIZE, BY WEANERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL SWINE VACCINES MARKET SIZE, BY WEANERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL SWINE VACCINES MARKET SIZE, BY WEANERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL SWINE VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL SWINE VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL SWINE VACCINES MARKET SIZE, BY INJECTION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL SWINE VACCINES MARKET SIZE, BY INJECTION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL SWINE VACCINES MARKET SIZE, BY INJECTION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL SWINE VACCINES MARKET SIZE, BY INJECTION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL SWINE VACCINES MARKET SIZE, BY INJECTION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL SWINE VACCINES MARKET SIZE, BY INJECTION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL SWINE VACCINES MARKET SIZE, BY NASAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL SWINE VACCINES MARKET SIZE, BY NASAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL SWINE VACCINES MARKET SIZE, BY NASAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL SWINE VACCINES MARKET SIZE, BY NASAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL SWINE VACCINES MARKET SIZE, BY NASAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL SWINE VACCINES MARKET SIZE, BY NASAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL SWINE VACCINES MARKET SIZE, BY ORAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL SWINE VACCINES MARKET SIZE, BY ORAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL SWINE VACCINES MARKET SIZE, BY ORAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL SWINE VACCINES MARKET SIZE, BY ORAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL SWINE VACCINES MARKET SIZE, BY ORAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL SWINE VACCINES MARKET SIZE, BY ORAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL SWINE VACCINES MARKET SIZE, BY PACKAGING TYPE, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL SWINE VACCINES MARKET SIZE, BY PACKAGING TYPE, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL SWINE VACCINES MARKET SIZE, BY MULTI DOSE BOTTLE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL SWINE VACCINES MARKET SIZE, BY MULTI DOSE BOTTLE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL SWINE VACCINES MARKET SIZE, BY MULTI DOSE BOTTLE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL SWINE VACCINES MARKET SIZE, BY MULTI DOSE BOTTLE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL SWINE VACCINES MARKET SIZE, BY MULTI DOSE BOTTLE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL SWINE VACCINES MARKET SIZE, BY MULTI DOSE BOTTLE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL SWINE VACCINES MARKET SIZE, BY PRE FILLED SYRINGE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL SWINE VACCINES MARKET SIZE, BY PRE FILLED SYRINGE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL SWINE VACCINES MARKET SIZE, BY PRE FILLED SYRINGE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL SWINE VACCINES MARKET SIZE, BY PRE FILLED SYRINGE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL SWINE VACCINES MARKET SIZE, BY PRE FILLED SYRINGE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL SWINE VACCINES MARKET SIZE, BY PRE FILLED SYRINGE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL SWINE VACCINES MARKET SIZE, BY VIAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL SWINE VACCINES MARKET SIZE, BY VIAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL SWINE VACCINES MARKET SIZE, BY VIAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL SWINE VACCINES MARKET SIZE, BY VIAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL SWINE VACCINES MARKET SIZE, BY VIAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL SWINE VACCINES MARKET SIZE, BY VIAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL SWINE VACCINES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL SWINE VACCINES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL SWINE VACCINES MARKET SIZE, BY COMMERCIAL FARMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL SWINE VACCINES MARKET SIZE, BY COMMERCIAL FARMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL SWINE VACCINES MARKET SIZE, BY COMMERCIAL FARMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL SWINE VACCINES MARKET SIZE, BY COMMERCIAL FARMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL SWINE VACCINES MARKET SIZE, BY COMMERCIAL FARMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL SWINE VACCINES MARKET SIZE, BY COMMERCIAL FARMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL SWINE VACCINES MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL SWINE VACCINES MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 139. GLOBAL SWINE VACCINES MARKET SIZE, BY RESEARCH INSTITUTES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL SWINE VACCINES MARKET SIZE, BY RESEARCH INSTITUTES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 141. GLOBAL SWINE VACCINES MARKET SIZE, BY RESEARCH INSTITUTES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL SWINE VACCINES MARKET SIZE, BY RESEARCH INSTITUTES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 143. GLOBAL SWINE VACCINES MARKET SIZE, BY VETERINARY CLINICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 144. GLOBAL SWINE VACCINES MARKET SIZE, BY VETERINARY CLINICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 145. GLOBAL SWINE VACCINES MARKET SIZE, BY VETERINARY CLINICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 146. GLOBAL SWINE VACCINES MARKET SIZE, BY VETERINARY CLINICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 147. GLOBAL SWINE VACCINES MARKET SIZE, BY VETERINARY CLINICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 148. GLOBAL SWINE VACCINES MARKET SIZE, BY VETERINARY CLINICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 149. GLOBAL SWINE VACCINES MARKET SIZE, BY VETERINARY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 150. GLOBAL SWINE VACCINES MARKET SIZE, BY VETERINARY HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 151. GLOBAL SWINE VACCINES MARKET SIZE, BY VETERINARY HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 152. GLOBAL SWINE VACCINES MARKET SIZE, BY VETERINARY HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 153. GLOBAL SWINE VACCINES MARKET SIZE, BY VETERINARY HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 154. GLOBAL SWINE VACCINES MARKET SIZE, BY VETERINARY HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 155. GLOBAL SWINE VACCINES MARKET SIZE, BY DISEASE TYPE, 2018-2024 (USD MILLION)
  • TABLE 156. GLOBAL SWINE VACCINES MARKET SIZE, BY DISEASE TYPE, 2025-2032 (USD MILLION)
  • TABLE 157. GLOBAL SWINE VACCINES MARKET SIZE, BY CLASSICAL SWINE FEVER, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 158. GLOBAL SWINE VACCINES MARKET SIZE, BY CLASSICAL SWINE FEVER, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 159. GLOBAL SWINE VACCINES MARKET SIZE, BY CLASSICAL SWINE FEVER, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 160. GLOBAL SWINE VACCINES MARKET SIZE, BY CLASSICAL SWINE FEVER, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 161. GLOBAL SWINE VACCINES MARKET SIZE, BY CLASSICAL SWINE FEVER, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 162. GLOBAL SWINE VACCINES MARKET SIZE, BY CLASSICAL SWINE FEVER, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 163. GLOBAL SWINE VACCINES MARKET SIZE, BY ERYSIPELAS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 164. GLOBAL SWINE VACCINES MARKET SIZE, BY ERYSIPELAS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 165. GLOBAL SWINE VACCINES MARKET SIZE, BY ERYSIPELAS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 166. GLOBAL SWINE VACCINES MARKET SIZE, BY ERYSIPELAS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 167. GLOBAL SWINE VACCINES MARKET SIZE, BY ERYSIPELAS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 168. GLOBAL SWINE VACCINES MARKET SIZE, BY ERYSIPELAS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 169. GLOBAL SWINE VACCINES MARKET SIZE, BY MYCOPLASMA PNEUMONIA, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 170. GLOBAL SWINE VACCINES MARKET SIZE, BY MYCOPLASMA PNEUMONIA, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 171. GLOBAL SWINE VACCINES MARKET SIZE, BY MYCOPLASMA PNEUMONIA, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 172. GLOBAL SWINE VACCINES MARKET SIZE, BY MYCOPLASMA PNEUMONIA, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 173. GLOBAL SWINE VACCINES MARKET SIZE, BY MYCOPLASMA PNEUMONIA, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 174. GLOBAL SWINE VACCINES MARKET SIZE, BY MYCOPLASMA PNEUMONIA, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 175. GLOBAL SWINE VACCINES MARKET SIZE, BY PORCINE CIRCOVIRUS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 176. GLOBAL SWINE VACCINES MARKET SIZE, BY PORCINE CIRCOVIRUS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 177. GLOBAL SWINE VACCINES MARKET SIZE, BY PORCINE CIRCOVIRUS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 178. GLOBAL SWINE VACCINES MARKET SIZE, BY PORCINE CIRCOVIRUS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 179. GLOBAL SWINE VACCINES MARKET SIZE, BY PORCINE CIRCOVIRUS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 180. GLOBAL SWINE VACCINES MARKET SIZE, BY PORCINE CIRCOVIRUS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 181. GLOBAL SWINE VACCINES MARKET SIZE, BY PORCINE REPRODUCTIVE AND RESPIRATORY SYNDROME, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 182. GLOBAL SWINE VACCINES MARKET SIZE, BY PORCINE REPRODUCTIVE AND RESPIRATORY SYNDROME, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 183. GLOBAL SWINE VACCINES MARKET SIZE, BY PORCINE REPRODUCTIVE AND RESPIRATORY SYNDROME, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 184. GLOBAL SWINE VACCINES MARKET SIZE, BY PORCINE REPRODUCTIVE AND RESPIRATORY SYNDROME, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 185. GLOBAL SWINE VACCINES MARKET SIZE, BY PORCINE REPRODUCTIVE AND RESPIRATORY SYNDROME, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 186. GLOBAL SWINE VACCINES MARKET SIZE, BY PORCINE REPRODUCTIVE AND RESPIRATORY SYNDROME, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 187. GLOBAL SWINE VACCINES MARKET SIZE, BY SWINE INFLUENZA, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 188. GLOBAL SWINE VACCINES MARKET SIZE, BY SWINE INFLUENZA, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 189. GLOBAL SWINE VACCINES MARKET SIZE, BY SWINE INFLUENZA, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 190. GLOBAL SWINE VACCINES MARKET SIZE, BY SWINE INFLUENZA, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 191. GLOBAL SWINE VACCINES MARKET SIZE, BY SWINE INFLUENZA, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 192. GLOBAL SWINE VACCINES MARKET SIZE, BY SWINE INFLUENZA, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 193. GLOBAL SWINE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 194. GLOBAL SWINE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 195. GLOBAL SWINE VACCINES MARKET SIZE, BY ONLINE PHARMACIES, 2018-2024 (USD MILLION)
  • TABLE 196. GLOBAL SWINE VACCINES MARKET SIZE, BY ONLINE PHARMACIES, 2025-2032 (USD MILLION)
  • TABLE 197. GLOBAL SWINE VACCINES MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 198. GLOBAL SWINE VACCINES MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 199. GLOBAL SWINE VACCINES MARKET SIZE, BY ONLINE PHARMACIES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 200. GLOBAL SWINE VACCINES MARKET SIZE, BY ONLINE PHARMACIES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 201. GLOBAL SWINE VACCINES MARKET SIZE, BY ONLINE PHARMACIES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 202. GLOBAL SWINE VACCINES MARKET SIZE, BY ONLINE PHARMACIES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 203. GLOBAL SWINE VACCINES MARKET SIZE, BY COMPANY WEBSITES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 204. GLOBAL SWINE VACCINES MARKET SIZE, BY COMPANY WEBSITES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 205. GLOBAL SWINE VACCINES MARKET SIZE, BY COMPANY WEBSITES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 206. GLOBAL SWINE VACCINES MARKET SIZE, BY COMPANY WEBSITES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 207. GLOBAL SWINE VACCINES MARKET SIZE, BY COMPANY WEBSITES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 208. GLOBAL SWINE VACCINES MARKET SIZE, BY COMPANY WEBSITES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 209. GLOBAL SWINE VACCINES MARKET SIZE, BY E COMMERCE PLATFORMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 210. GLOBAL SWINE VACCINES MARKET SIZE, BY E COMMERCE PLATFORMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 211. GLOBAL SWINE VACCINES MARKET SIZE, BY E COMMERCE PLATFORMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 212. GLOBAL SWINE VACCINES MARKET SIZE, BY E COMMERCE PLATFORMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 213. GLOBAL SWINE VACCINES MARKET SIZE, BY E COMMERCE PLATFORMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 214. GLOBAL SWINE VACCINES MARKET SIZE, BY E COMMERCE PLATFORMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 215. GLOBAL SWINE VACCINES MARKET SIZE, BY VETERINARY CLINICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 216. GLOBAL SWINE VACCINES MARKET SIZE, BY VETERINARY CLINICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 217. GLOBAL SWINE VACCINES MARKET SIZE, BY VETERINARY CLINICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 218. GLOBAL SWINE VACCINES MARKET SIZE, BY VETERINARY CLINICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 219. GLOBAL SWINE VACCINES MARKET SIZE, BY VETERINARY CLINICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 220. GLOBAL SWINE VACCINES MARKET SIZE, BY VETERINARY CLINICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 221. GLOBAL SWINE VACCINES MARKET SIZE, BY VETERINARY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 222. GLOBAL SWINE VACCINES MARKET SIZE, BY VETERINARY HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 223. GLOBAL SWINE VACCINES MARKET SIZE, BY VETERINARY HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 224. GLOBAL SWINE VACCINES MARKET SIZE, BY VETERINARY HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 225. GLOBAL SWINE VACCINES MARKET SIZE, BY VETERINARY HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 226. GLOBAL SWINE VACCINES MARKET SIZE, BY VETERINARY HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 227. GLOBAL SWINE VACCINES MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 228. GLOBAL SWINE VACCINES MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 229. AMERICAS SWINE VACCINES MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 230. AMERICAS SWINE VACCINES MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 231. AMERICAS SWINE VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
  • TABLE 232. AMERICAS SWINE VACCINES MARKET SIZE, BY VACCINE TYPE, 2025-2032 (USD MILLION)
  • TABLE 233. AMERICAS SWINE VACCINES MARKET SIZE, BY ANIMAL AGE, 2018-2024 (USD MILLION)
  • TABLE 234. AMERICAS SWINE VACCINES MARKET SIZE, BY ANIMAL AGE, 2025-2032 (USD MILLION)
  • TABLE 235. AMERICAS SWINE VACCINES MARKET SIZE, BY BREEDERS, 2018-2024 (USD MILLION)
  • TABLE 236. AMERICAS SWINE VACCINES MARKET SIZE, BY BREEDERS, 2025-2032 (USD MILLION)
  • TABLE 237. AMERICAS SWINE VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
  • TABLE 238. AMERICAS SWINE VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2032 (USD MILLION)
  • TABLE 239. AMERICAS SWINE VACCINES MARKET SIZE, BY PACKAGING TYPE, 2018-2024 (USD MILLION)
  • TABLE 240. AMERICAS SWINE VACCINES MARKET SIZE, BY PACKAGING TYPE, 2025-2032 (USD MILLION)
  • TABLE 241. AMERICAS SWINE VACCINES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 242. AMERICAS SWINE VACCINES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 243. AMERICAS SWINE VACCINES MARKET SIZE, BY DISEASE TYPE, 2018-2024 (USD MILLION)
  • TABLE 244. AMERICAS SWINE VACCINES MARKET SIZE, BY DISEASE TYPE, 2025-2032 (USD MILLION)
  • TABLE 245. AMERICAS SWINE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 246. AMERICAS SWINE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 247. AMERICAS SWINE VACCINES MARKET SIZE, BY ONLINE PHARMACIES, 2018-2024 (USD MILLION)
  • TABLE 248. AMERICAS SWINE VACCINES MARKET SIZE, BY ONLINE PHARMACIES, 2025-2032 (USD MILLION)
  • TABLE 249. NORTH AMERICA SWINE VACCINES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 250. NORTH AMERICA SWINE VACCINES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 251. NORTH AMERICA SWINE VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
  • TABLE 252. NORTH AMERICA SWINE VACCINES MARKET SIZE, BY VACCINE TYPE, 2025-2032 (USD MILLION)
  • TABLE 253. NORTH AMERICA SWINE VACCINES MARKET SIZE, BY ANIMAL AGE, 2018-2024 (USD MILLION)
  • TABLE 254. NORTH AMERICA SWINE VACCINES MARKET SIZE, BY ANIMAL AGE, 2025-2032 (USD MILLION)
  • TABLE 255. NORTH AMERICA SWINE VACCINES MARKET SIZE, BY BREEDERS, 2018-2024 (USD MILLION)
  • TABLE 256. NORTH AMERICA SWINE VACCINES MARKET SIZE, BY BREEDERS, 2025-2032 (USD MILLION)
  • TABLE 257. NORTH AMERICA SWINE VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
  • TABLE 258. NORTH AMERICA SWINE VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2032 (USD MILLION)
  • TABLE 259. NORTH AMERICA SWINE VACCINES MARKET SIZE, BY PACKAGING TYPE, 2018-2024 (USD MILLION)
  • TABLE 260. NORTH AMERICA SWINE VACCINES MARKET SIZE, BY PACKAGING TYPE, 2025-2032 (USD MILLION)
  • TABLE 261. NORTH AMERICA SWINE VACCINES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 262. NORTH AMERICA SWINE VACCINES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 263. NORTH AMERICA SWINE VACCINES MARKET SIZE, BY DISEASE TYPE, 2018-2024 (USD MILLION)
  • TABLE 264. NORTH AMERICA SWINE VACCINES MARKET SIZE, BY DISEASE TYPE, 2025-2032 (USD MILLION)
  • TABLE 265. NORTH AMERICA SWINE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 266. NORTH AMERICA SWINE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 267. NORTH AMERICA SWINE VACCINES MARKET SIZE, BY ONLINE PHARMACIES, 2018-2024 (USD MILLION)
  • TABLE 268. NORTH AMERICA SWINE VACCINES MARKET SIZE, BY ONLINE PHARMACIES, 2025-2032 (USD MILLION)
  • TABLE 269. LATIN AMERICA SWINE VACCINES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 270. LATIN AMERICA SWINE VACCINES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 271. LATIN AMERICA SWINE VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
  • TABLE 272. LATIN AMERICA SWINE VACCINES MARKET SIZE, BY VACCINE TYPE, 2025-2032 (USD MILLION)
  • TABLE 273. LATIN AMERICA SWINE VACCINES MARKET SIZE, BY ANIMAL AGE, 2018-2024 (USD MILLION)
  • TABLE 274. LATIN AMERICA SWINE VACCINES MARKET SIZE, BY ANIMAL AGE, 2025-2032 (USD MILLION)
  • TABLE 275. LATIN AMERICA SWINE VACCINES MARKET SIZE, BY BREEDERS, 2018-2024 (USD MILLION)
  • TABLE 276. LATIN AMERICA SWINE VACCINES MARKET SIZE, BY BREEDERS, 2025-2032 (USD MILLION)
  • TABLE 277. LATIN AMERICA SWINE VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
  • TABLE 278. LATIN AMERICA SWINE VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2032 (USD MILLION)
  • TABLE 279. LATIN AMERICA SWINE VACCINES MARKET SIZE, BY PACKAGING TYPE, 2018-2024 (USD MILLION)
  • TABLE 280. LATIN AMERICA SWINE VACCINES MARKET SIZE, BY PACKAGING TYPE, 2025-2032 (USD MILLION)
  • TABLE 281. LATIN AMERICA SWINE VACCINES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 282. LATIN AMERICA SWINE VACCINES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 283. LATIN AMERICA SWINE VACCINES MARKET SIZE, BY DISEASE TYPE, 2018-2024 (USD MILLION)
  • TABLE 284. LATIN AMERICA SWINE VACCINES MARKET SIZE, BY DISEASE TYPE, 2025-2032 (USD MILLION)
  • TABLE 285. LATIN AMERICA SWINE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 286. LATIN AMERICA SWINE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 287. LATIN AMERICA SWINE VACCINES MARKET SIZE, BY ONLINE PHARMACIES, 2018-2024 (USD MILLION)
  • TABLE 288. LATIN AMERICA SWINE VACCINES MARKET SIZE, BY ONLINE PHARMACIES, 2025-2032 (USD MILLION)
  • TABLE 289. EUROPE, MIDDLE EAST & AFRICA SWINE VACCINES MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 290. EUROPE, MIDDLE EAST & AFRICA SWINE VACCINES MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 291. EUROPE, MIDDLE EAST & AFRICA SWINE VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
  • TABLE 292. EUROPE, MIDDLE EAST & AFRICA SWINE VACCINES MARKET SIZE, BY VACCINE TYPE, 2025-2032 (USD MILLION)
  • TABLE 293. EUROPE, MIDDLE EAST & AFRICA SWINE VACCINES MARKET SIZE, BY ANIMAL AGE, 2018-2024 (USD MILLION)
  • TABLE 294. EUROPE, MIDDLE EAST & AFRICA SWINE VACCINES MARKET SIZE, BY ANIMAL AGE, 2025-2032 (USD MILLION)
  • TABLE 295. EUROPE, MIDDLE EAST & AFRICA SWINE VACCINES MARKET SIZE, BY BREEDERS, 2018-2024 (USD MILLION)
  • TABLE 296. EUROPE, MIDDLE EAST & AFRICA SWINE VACCINES MARKET SIZE, BY BREEDERS, 2025-2032 (USD MILLION)
  • TABLE 297. EUROPE, MIDDLE EAST & AFRICA SWINE VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
  • TABLE 298. EUROPE, MIDDLE EAST & AFRICA SWINE VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2032 (USD MILLION)
  • TABLE 299. EUROPE, MIDDLE EAST & AFRICA SWINE VACCINES MARKET SIZE, BY PACKAGING TYPE, 2018-2024 (USD MILLION)
  • TABLE 300. EUROPE, MIDDLE EAST & AFRICA SWINE VACCINES MARKET SIZE, BY PACKAGING TYPE, 2025-2032 (USD MILLION)
  • TABLE 301. EUROPE, MIDDLE EAST & AFRICA SWINE VACCINES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 302. EUROPE, MIDDLE EAST & AFRICA SWINE VACCINES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 303. EUROPE, MIDDLE EAST & AFRICA SWINE VACCINES MARKET SIZE, BY DISEASE TYPE, 2018-2024 (USD MILLION)
  • TABLE 304. EUROPE, MIDDLE EAST & AFRICA SWINE VACCINES MARKET SIZE, BY DISEASE TYPE, 2025-2032 (USD MILLION)
  • TABLE 305. EUROPE, MIDDLE EAST & AFRICA SWINE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 306. EUROPE, MIDDLE EAST & AFRICA SWINE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 307. EUROPE, MIDDLE EAST & AFRICA SWINE VACCINES MARKET SIZE, BY ONLINE PHARMACIES, 2018-2024 (USD MILLION)
  • TABLE 308. EUROPE, MIDDLE EAST & AFRICA SWINE VACCINES MARKET SIZE, BY ONLINE PHARMACIES, 2025-2032 (USD MILLION)
  • TABLE 309. EUROPE SWINE VACCINES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 310. EUROPE SWINE VACCINES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 311. EUROPE SWINE VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
  • TABLE 312. EUROPE SWINE VACCINES MARKET SIZE, BY VACCINE TYPE, 2025-2032 (USD MILLION)
  • TABLE 313. EUROPE SWINE VACCINES MARKET SIZE, BY ANIMAL AGE, 2018-2024 (USD MILLION)
  • TABLE 314. EUROPE SWINE VACCINES MARKET SIZE, BY ANIMAL AGE, 2025-2032 (USD MILLION)
  • TABLE 315. EUROPE SWINE VACCINES MARKET SIZE, BY BREEDERS, 2018-2024 (USD MILLION)
  • TABLE 316. EUROPE SWINE VACCINES MARKET SIZE, BY BREEDERS, 2025-2032 (USD MILLION)
  • TABLE 317. EUROPE SWINE VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
  • TABLE 318. EUROPE SWINE VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2032 (USD MILLION)
  • TABLE 319. EUROPE SWINE VACCINES MARKET SIZE, BY PACKAGING TYPE, 2018-2024 (USD MILLION)
  • TABLE 320. EUROPE SWINE VACCINES MARKET SIZE, BY PACKAGING TYPE, 2025-2032 (USD MILLION)
  • TABLE 321. EUROPE SWINE VACCINES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 322. EUROPE SWINE VACCINES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 323. EUROPE SWINE VACCINES MARKET SIZE, BY DISEASE TYPE, 2018-2024 (USD MILLION)
  • TABLE 324. EUROPE SWINE VACCINES MARKET SIZE, BY DISEASE TYPE, 2025-2032 (USD MILLION)
  • TABLE 325. EUROPE SWINE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 326. EUROPE SWINE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 327. EUROPE SWINE VACCINES MARKET SIZE, BY ONLINE PHARMACIES, 2018-2024 (USD MILLION)
  • TABLE 328. EUROPE SWINE VACCINES MARKET SIZE, BY ONLINE PHARMACIES, 2025-2032 (USD MILLION)
  • TABLE 329. MIDDLE EAST SWINE VACCINES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 330. MIDDLE EAST SWINE VACCINES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 331. MIDDLE EAST SWINE VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
  • TABLE 332. MIDDLE EAST SWINE VACCINES MARKET SIZE, BY VACCINE TYPE, 2025-2032 (USD MILLION)
  • TABLE 333. MIDDLE EAST SWINE VACCINES MARKET SIZE, BY ANIMAL AGE, 2018-2024 (USD MILLION)
  • TABLE 334. MIDDLE EAST SWINE VACCINES MARKET SIZE, BY ANIMAL AGE, 2025-2032 (USD MILLION)
  • TABLE 335. MIDDLE EAST SWINE VACCINES MARKET SIZE, BY BREEDERS, 2018-2024 (USD MILLION)
  • TABLE 336. MIDDLE EAST SWINE VACCINES MARKET SIZE, BY BREEDERS, 2025-2032 (USD MILLION)
  • TABLE 337. MIDDLE EAST SWINE VACCIN